SCHEMBL27992133

SCHEMBL27992133

CCC(O)C(NC(=O)O)c1ccccc1Cl

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CASP1 P29466 1/20 0.46
CTSA P10619 4/20 0.43
ADRB2 P07550 2/20 0.42
ADRB1 P08588 2/20 0.42
CYP2D6 P10635 1/20 0.41
NFKB1 P19838 1/20 0.41
HIF1A Q16665 1/20 0.41
KCNQ2 O43526 1/20 0.40
BLM P54132 1/20 0.40
LMNA P02545 1/20 0.40
HPGD P15428 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
TAS1R3 Q7RTX0 2/20 0.39
TAS1R1 Q7RTX1 2/20 0.39
ALDH1A1 P00352 1/20 0.39
TAS1R2 Q8TE23 1/20 0.39
KDM4E B2RXH2 1/20 0.39
GAA P10253 1/20 0.39
AOC3 Q16853 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15067572 0.83 TAS1R3 (0.43) CASP1KCNQ2LMNAHPGDSMN1; SMN2
SCHEMBL16054219 0.83 TAS1R3 (0.43) CASP1KCNQ2LMNAHPGDSMN1; SMN2
SCHEMBL16054482 0.83 TAS1R3 (0.43) CASP1KCNQ2LMNAHPGDSMN1; SMN2
SCHEMBL27992292 0.83 TRPA1 (0.37) CYP2D6LMNAHPGDSMN1; SMN2ALDH1A1
SCHEMBL15067585 0.83 ADRB2 (0.45) CASP1CTSAADRB2ADRB1CYP2D6
SCHEMBL15067895 0.83 ADRB2 (0.45) CASP1CTSAADRB2ADRB1CYP2D6
SCHEMBL15067442 0.83 ADRB2 (0.45) CASP1CTSAADRB2ADRB1CYP2D6
SCHEMBL15066249 0.82 TAS1R3 (0.45) TAS1R3TAS1R1
SCHEMBL15069770 0.82 TAS1R3 (0.45) TAS1R3TAS1R1
SCHEMBL16054408 0.82 TAS1R3 (0.45) TAS1R3TAS1R1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111419830-B Phenylalkylcarbamate compounds for use in the prevention or treatment of epilepsy and epileptic related syndromes 比皮艾思药物研发有限公司 2024-01-30 CN disclosed
CN-115996905-A Phenylalkyl carbamate compounds for use in preventing or treating neurodegenerative diseases 生物药品解决方案有限公司 2023-04-21 CN disclosed
CN-104136416-B Phenylalkylamino carbamate derivatives compound and comprise the pharmaceutical composition of this Phenylalkylamino carbamate derivatives compound 比皮艾思药物研发有限公司 2016-11-09 CN disclosed
CN-105209027-A Phenylalkylcarbamate compounds for use in the prevention or treatment of epilepsy and epilepsy-related syndromes BIO PHARM SOLUTIONS CO LTD 2015-12-30 CN disclosed
CN-104136416-A Phenyl alkyl carbamate derivative compound and pharmaceutical composition containing the same BIO PHARM SOLUTIONS CO LTD 2014-11-05 CN disclosed